Management

Unni Hjelmaas

Unni Hjelmaas

Acting Chief Executive Officer

Unni Hjelmaas (born 1963) has been engaged as Acting CEO since 1 May 2016. Unni Hjelmaas holds extensive experience from several international and Norwegian senior management positions in Roche from 1990-2012, including General Manager of Roche Norway 2003-2012. Areas of responsibility has included launch, market access and phase II/III/IV clinical trial program planning, marketing and sales across various therapeutic areas (oncology, virology, rheumatology, cardiovascular, metabolic diseases, hematology, transplantation), as well as international oncology strategy, life-cycle management and alliance management. CEO of Norwegian biotech start up Lytix Biopharma 2012-2016, a private clinical-phase cancer immunoterapy company. Independent biotech/pharma industry consultant as of April 2016. Previous Chairman and current Co-Chairman of the Board of the Norwegian Pharma Industry Association and Member of the Board of Oslo Cancer Cluster. Master of Science in Pharmacy (cand.pharm/MPharm) from the University of Oslo.
Gunnar Flåten

Gunnar Flåten

VP Director of Finance

Gunnar Flåten holds a Master of Science in Business Administration from Norwegian School of Economics (NHH). Experience in finance, sales and administration in Bionor Pharma ASA, Bionor Immuno AS and Bionor AS since 1986. Previous experience as a consultant in an administration and financial institution.

Maja Sommerfelt, Ph.D.

Maja Sommerfelt, Ph.D.

SVP Chief Scientific Officer

Maja Sommerfelt has a BSc. in microbiology from the University of London and a PhD in virology from the Institute of Cancer Research at the University of London, UK. She has carried out post-doctoral research at the University of Alabama at Birmingham, USA, and at the University of Bergen where she became professor. She has over 30 years research experience within HIV, immunology, vaccines and infectious disease, where the last 15 years have been in industry.
Mats Ökvist

Mats Ökvist

Chief Patent & Technology Officer

Mats Ökvist, PhD, joined the company in November 2011. He has a background in Structural Biology, with over 10 years of experience from determination and analysis of proteins structures.